Literature DB >> 6363620

Immunogenic properties of the small chain HA2 of the haemagglutinin of influenza viruses.

H Becht, R T Huang, B Fleischer, C B Boschek, R Rott.   

Abstract

The small chain of influenza virus haemagglutinin, HA2 was isolated by a selective enzymic removal of HA1 or by preparative SDS-polyacrylamide gel electrophoresis. Anti-HA2 specific antisera and monoclonal antibodies were subtype-specific in immunodiffusion tests and radioimmunoassays. These antibodies did not inhibit haemagglutination or haemolysis, did not prevent virus release, did not neutralize infectivity, and HA2 did not induce a protective immunity. HA2-specific antigenic determinants could not be demonstrated on the surface of infected cells. Lymphocytes from pre-immunized mice could not be stimulated by HA2 to exert a cytotoxic effect.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6363620     DOI: 10.1099/0022-1317-65-1-173

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  16 in total

1.  Epitope specificity of anti-HA2 antibodies induced in humans during influenza infection.

Authors:  Zuzana Staneková; Vojtech Mucha; Tatiana Sládková; Hana Blaškovičová; František Kostolanský; Eva Varečková
Journal:  Influenza Other Respir Viruses       Date:  2012-01-12       Impact factor: 4.380

2.  Conservation of epitopes recognized by monoclonal antibodies against the separated subunits of influenza hemagglutinin among type A viruses of the same and different subtypes.

Authors:  A Sanchez-Fauquier; M Guillen; J Martin; A P Kendal; J A Melero
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

3.  Structure and assembly of hemagglutinin mutants of fowl plague virus with impaired surface transport.

Authors:  W Garten; C Will; K Buckard; K Kuroda; D Ortmann; K Munk; C Scholtissek; H Schnittler; D Drenckhahn; H D Klenk
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

4.  Monoclonal antibodies demonstrate accessible HA2 epitopes in minor subpopulation of native influenza virus haemagglutinin molecules.

Authors:  E Varecková; V Mucha; F Ciampor; T Betáková; G Russ
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

5.  Changes in the influenza virus haemagglutinin at acid pH detected by monoclonal antibodies to glycopolypeptides HA1 and HA2.

Authors:  F Kostolansky; G Russ; V Mucha; B Styk
Journal:  Arch Virol       Date:  1988       Impact factor: 2.574

6.  Isolation of cross-reactive, subtype-specific monoclonal antibodies against influenza virus HA1 and HA2 hemagglutinin subunits.

Authors:  A Sánchez-Fauquier; N Villanueva; J A Melero
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

7.  A pulmonary influenza virus infection in SCID mice can be cured by treatment with hemagglutinin-specific antibodies that display very low virus-neutralizing activity in vitro.

Authors:  K Mozdzanowska; M Furchner; G Washko; J Mozdzanowski; W Gerhard
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

8.  Recognition of cloned influenza virus hemagglutinin gene products by cytotoxic T lymphocytes.

Authors:  J R Bennink; J W Yewdell; G L Smith; B Moss
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

9.  Synthesis of biologically active influenza virus hemagglutinin in insect larvae.

Authors:  K Kuroda; A Gröner; K Frese; D Drenckhahn; C Hauser; R Rott; W Doerfler; H D Klenk
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

10.  Human CD4+ T-cell repertoire of responses to influenza A virus hemagglutinin after recent natural infection.

Authors:  C M Gelder; K I Welsh; A Faith; J R Lamb; B A Askonas
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.